The M&A-focused Betaville blog sent an alert to its subscribers related to a rumor regarding Janux Therapeutics (JANX), contacts tell The Fly.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JANX:
- Janux Therapeutics Advances with Promising Study on JANX008 for Solid Tumor Treatment
- Janux Therapeutics Advances Prostate Cancer Study with JANX007
- BTIG biotech analyst holds an analyst/industry conference call
- Janux Therapeutics Announces Departure of Chief Strategy Officer
- Janux Therapeutics initiated with an Overweight at Barclays